LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 330

Search options

  1. Article ; Online: Very low-volume interval training improves nonalcoholic fatty liver disease fibrosis score and cardiometabolic health in adults with obesity and metabolic syndrome.

    Reljic, D / Konturek, P C / Herrmann, H J / Siebler, J / Neurath, M F / Zopf, Y

    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

    2022  Volume 72, Issue 6

    Abstract: Non-alcoholic fatty liver disease (NAFLD) and cardiometabolic disorders are highly prevalent in obese individuals. Physical exercise is an important element in obesity and metabolic syndrome (MetS) treatment. However, the vast majority of individuals ... ...

    Abstract Non-alcoholic fatty liver disease (NAFLD) and cardiometabolic disorders are highly prevalent in obese individuals. Physical exercise is an important element in obesity and metabolic syndrome (MetS) treatment. However, the vast majority of individuals with obesity do not meet the general physical activity recommendations (i.e. 150 min of moderate activity per week). The present study aimed to investigate the impact of a highly time-saving high-intensity interval training (HIIT) protocol (28 min time requirement per week) on NAFLD fibrosis (NFS) and cardiometabolic risk scores in obese patients with MetS and elevated NFS values. Twenty-nine patients performed HIIT on cycle ergometers (5 x 1 min at an intensity of 80 - 95% maximal heart rate) twice weekly for 12 weeks and were compared to a control group without exercise (CON, n = 17). Nutritional counseling for weight loss was provided to both groups. NFS, cardiometabolic risk indices, MetS z-score, cardiorespiratory fitness (VO
    MeSH term(s) Adult ; Cardiovascular Diseases ; Fibrosis ; Humans ; Metabolic Syndrome/therapy ; Non-alcoholic Fatty Liver Disease/complications ; Non-alcoholic Fatty Liver Disease/therapy ; Obesity/complications ; Obesity/therapy ; Weight Loss
    Language English
    Publishing date 2022-04-24
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 1125221-2
    ISSN 1899-1505 ; 0867-5910 ; 0044-6033
    ISSN (online) 1899-1505
    ISSN 0867-5910 ; 0044-6033
    DOI 10.26402/jpp.2021.6.10
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Therapeutische Modulation der Darmmikrobiota beim Reizdarmsyndrom : Von Probiotika bis zur fäkalen Mikrobiota-Therapie.

    Konturek, P C / Zopf, Yurdagül

    MMW Fortschritte der Medizin

    2017  Volume 159, Issue Suppl 7, Page(s) 1–5

    Abstract: Background: An abnormal intestinal microbiota (dysbiosis) plays a central role in the pathogenesis of the irritable bowel syndrome.: Method: An overview of four current options for the treatment of irritable bowel syndrome, which are characterized by ...

    Title translation Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy.
    Abstract Background: An abnormal intestinal microbiota (dysbiosis) plays a central role in the pathogenesis of the irritable bowel syndrome.
    Method: An overview of four current options for the treatment of irritable bowel syndrome, which are characterized by modulation of intestinal microbiota, is given.
    Results and conclusions: Probiotics have very different effects on the individual symptoms of the irritable bowel. The choice of the appropriate preparation should therefore be based on the clinical symptomatology. The antibiotic rifaximin is effective in selected patients. Some patients also benefit from the repetition of this therapy. A FODMAP-reduced diet has shown significant alleviation of irritable bowel symptoms in studies. The fecal microbiota therapy (FMT) is a promising treatment option. At present, however, there are no such placebo-controlled studies to assess the effectiveness of this method.
    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Fecal Microbiota Transplantation ; Gastrointestinal Microbiome/drug effects ; Humans ; Irritable Bowel Syndrome/therapy ; Probiotics/therapeutic use
    Chemical Substances Anti-Bacterial Agents
    Language German
    Publishing date 2017-12
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1478211-x
    ISSN 1613-3560 ; 1438-3276
    ISSN (online) 1613-3560
    ISSN 1438-3276
    DOI 10.1007/s15006-017-0338-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation.

    Nicco, Carole / Paule, Armelle / Konturek, Peter / Edeas, Marvin

    Diseases (Basel, Switzerland)

    2020  Volume 8, Issue 2

    Abstract: Fecal Microbiota Transplantation (FMT) is suggested as an efficacious therapeutic strategy for restoring intestinal microbial balance, and thus for treating disease associated with alteration of gut microbiota. FMT consists of the administration of fresh ...

    Abstract Fecal Microbiota Transplantation (FMT) is suggested as an efficacious therapeutic strategy for restoring intestinal microbial balance, and thus for treating disease associated with alteration of gut microbiota. FMT consists of the administration of fresh or frozen fecal microorganisms from a healthy donor into the intestinal tract of diseased patients. At this time, in according to healthcare authorities, FMT is mainly used to treat recurrent
    Keywords covid19
    Language English
    Publishing date 2020-04-15
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2720869-2
    ISSN 2079-9721
    ISSN 2079-9721
    DOI 10.3390/diseases8020009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Effect of substance P and its C-terminal hexapeptide on gastric and pancreatic secretion in the dog.

    Konturek, S J / Jaworek, J / Tasler, J / Cieszkowski, M / Pawlik, W

    The American journal of physiology

    1981  Volume 241, Issue 1, Page(s) G74–81

    Abstract: ... of substance P (SP) and its C-terminal hexapeptide (SP6-11) on gastric acid and pancreatic secretions were ... indicating that the C-terminal portion of SP exhibits a full spectrum of the biological action of the intact ...

    Abstract In five dogs with gastric fistulas, Heidenhain pouches, and pancreatic fistulas, the effects of substance P (SP) and its C-terminal hexapeptide (SP6-11) on gastric acid and pancreatic secretions were determined under basal conditions and in response to secretory stimulation. SP or SP6-11 infused alone in graded doses (0.25-2.0 nmol.kg-1.h-1) caused a slight but significant increase in pancreatic secretions in fasted dogs, but, when given during the secretory stimulation, they caused significant inhibition of these secretions. They reduced gastric acid response to pentagastrin and peptone meal without affecting the serum gastrin level. They caused dose-dependent inhibition of secretin-induced pancreatic bicarbonate secretion and suppressed the pancreatic protein response to caerulein, feeding, and duodenal acidification. SP6-11 was equipotent on a molar basis with SP in the inhibition of gastric or pancreatic secretion, indicating that the C-terminal portion of SP exhibits a full spectrum of the biological action of the intact molecule. The inhibitory effects of SP and SP6-11 on the stomach and pancreas were observed at a dose range that was without any significant influence on the blood pressure, indicating that they are not caused by the interference of the blood flow to the pancreas.
    MeSH term(s) Animals ; Bicarbonates/metabolism ; Blood Pressure/drug effects ; Dogs ; Dose-Response Relationship, Drug ; Duodenum/physiology ; Gastric Juice/drug effects ; Gastric Juice/secretion ; Heart Rate/drug effects ; Hydrogen-Ion Concentration ; Kinetics ; Pancreatic Juice/drug effects ; Pancreatic Juice/secretion ; Peptide Fragments/pharmacology ; Proteins/secretion ; Pyrrolidonecarboxylic Acid/analogs & derivatives ; Substance P/analogs & derivatives ; Substance P/pharmacology
    Chemical Substances Bicarbonates ; Peptide Fragments ; Proteins ; Substance P (33507-63-0) ; substance P (6-11) (51165-07-2) ; Pyrrolidonecarboxylic Acid (SZB83O1W42)
    Language English
    Publishing date 1981-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2948-8
    ISSN 0002-9513
    ISSN 0002-9513
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: COVID-19 - more than respiratory disease: a gastroenterologist's perspective.

    Konturek, P C / Harsch, I A / Neurath, M F / Zopf, Y

    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

    2020  Volume 71, Issue 2

    Abstract: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2) outbreak is the most dramatic event since World War II. Originating as a cluster of unexplained cases of pneumonia, it turned out that this viral disease termed COVID-19 is not only a ... ...

    Abstract Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2) outbreak is the most dramatic event since World War II. Originating as a cluster of unexplained cases of pneumonia, it turned out that this viral disease termed COVID-19 is not only a respiratory infection, but a systemic disease associated with a number of extrapulmonary complications. One of the medical disciplines that is strongly affected by this viral infection is gastroenterology. COVID-19 causes in some patients typical symptoms of enteritis such as diarrhea or abdominal pain. There is also evidence that this infection may lead to liver and pancreatic injury. Since the SARS-CoV2 virus was detected in stool, a fecal-oral route of transmission is possible. Moreover, viral receptor angiotensin converting enzyme 2 (ACE2) is highly expressed in the gastrointestinal tract and enables the invasion of the gastrointestinal epithelium as demonstrated in vitro and in vivo. COVID-19 pandemic has an impact on the daily practice and the workflows in endoscopy leading to a dramatic decrease of screening and surveillance procedures. COVID-19 impacts the therapy of patients with inflammatory bowel disease (IBD), particularly those using high doses of corticosteroids, immunosuppressive agents and biologics. Patients with preexisting liver disease, especially metabolic associated liver fatty disease (MALFD) with fibrosis or liver cirrhosis, are at high risk for severe COVID-19. As long as no active vaccine against SARS-CoV2 is available, gastroenterologists have to be aware of these problems that affect their daily routine practice.
    MeSH term(s) Animals ; Betacoronavirus/isolation & purification ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/physiopathology ; Coronavirus Infections/therapy ; Disease Outbreaks ; Gastroenterologists ; Gastrointestinal Diseases/physiopathology ; Gastrointestinal Diseases/therapy ; Gastrointestinal Diseases/virology ; Humans ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/physiopathology ; Pneumonia, Viral/therapy ; Risk Factors ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-07-02
    Publishing country Poland
    Document type Journal Article ; Review
    ZDB-ID 1125221-2
    ISSN 1899-1505 ; 0867-5910 ; 0044-6033
    ISSN (online) 1899-1505
    ISSN 0867-5910 ; 0044-6033
    DOI 10.26402/jpp.2020.2.02
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: CME Zertifizierte Fortbildung. Reizdarmsyndrom. Diagnostik und therapeutische Optionen. Irritable bowel syndrome. Diagnosis and therapeutic options / Testfragen

    Konturek, P. C.

    Tägliche Praxis

    2014  Volume 55, Issue 2, Page(s) 249/259

    Language German
    Document type Article
    ZDB-ID 506157-x
    ISSN 0494-464X
    Database Current Contents Medicine

    More links

    Kategorien

  7. Article: CME Zertifizierte Fortbildung. Teilnahmebedingungen und Testbogen / Reizdarmsyndrom. Diagnostik und therapeutische Optionen. Irritable bowel syndrome. Diagnosis and therapeutic options / Testfragen / Auflösung aus Band 54, Heft 1

    Konturek, P. C.

    Internistische Praxis

    2014  Volume 54, Issue 2, Page(s) 267/269/279/281

    Language German
    Document type Article
    ZDB-ID 209039-9
    ISSN 0020-9570
    Database Current Contents Medicine

    More links

    Kategorien

  8. Article ; Online: Hypoglycemic side effects of sulfonylureas and repaglinide in ageing patients - knowledge and self-management.

    Harsch, I A / Kaestner, R H / Konturek, P C

    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

    2018  Volume 69, Issue 4

    Abstract: Insulinotropic oral antidiabetics (OAD) such as sulfonylureas and (SU) glinides are among the frequently prescribed OAD. Side effects are the potential to induce hypoglycemias and weight gain. The aim was to assess the self-managing skills in case of a ... ...

    Abstract Insulinotropic oral antidiabetics (OAD) such as sulfonylureas and (SU) glinides are among the frequently prescribed OAD. Side effects are the potential to induce hypoglycemias and weight gain. The aim was to assess the self-managing skills in case of a hypoglycemic event in an elderly type 2 diabetic patient population. In a 2-year period, 160 hospitalized patients (mean age 77.4 years) under insulinotrophic OAD were interviewed using a standardized questionnaire. Additionally, possible dementia was evaluated by using the Mini-Mental State Examination (MMSE) and the Clock-Drawing Test (CDT). The mean HbA1c was 7.6%. MMSE and CDT did intraindividually correlate well and 23.8% of the patients had moderate dementia (10 - 20 points MMSE), 13.1% had severe dementia (0 - 10 points MMSE) at the time of the survey. When under treatment with a sulfonylurea, only 16.0% of patients were aware of the potential hypoglycemia-inducing side effect. Moreover, only 11.8% of patients treated with a combination of a sulfonylurea and insulin knew this side effect of the OAD. The awareness of the side effects of repaglinide was 21.6% (without insulin therapy) versus 21.4% in the insulin-comedicated group. Only 42.6% of patients treated with sulfonylureas or repaglinide knew how to act in the case of hypoglycemia. Even under comedication with insulin, only in 41.2% of the respondents in the comedicated group knew how to take action if they were to experience hypoglycemia. Our findings raise concerns and demonstrate, that the self-managing skills in an elderly patient group are not good, which may become an increasing problem in an ageing population. The prescription or the re-prescription of insulinotropic OAD needs to be adapted to the current cognitive situation and re-evaluated regularly.
    MeSH term(s) Aged ; Aged, 80 and over ; Aging ; Carbamates/adverse effects ; Diabetes Mellitus, Type 2/drug therapy ; Drug Therapy, Combination ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemic Agents/adverse effects ; Male ; Middle Aged ; Piperidines/adverse effects ; Self-Management ; Sulfonylurea Compounds/adverse effects
    Chemical Substances Carbamates ; Hypoglycemic Agents ; Piperidines ; Sulfonylurea Compounds ; repaglinide (668Z8C33LU)
    Language English
    Publishing date 2018-12-09
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 1125221-2
    ISSN 1899-1505 ; 0867-5910 ; 0044-6033
    ISSN (online) 1899-1505
    ISSN 0867-5910 ; 0044-6033
    DOI 10.26402/jpp.2018.4.15
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Impact of autofluorescence for detection of parathyroid glands during thyroidectomy on postoperative parathyroid hormone levels: parallel multicentre randomized clinical trial.

    Bergenfelz, Anders / Barczynski, Marcin / Heie, Anette / Muth, Andreas / Passler, Christian / Schneider, Max / Wierzbicka, Paulina / Konturek, Alexander / Brauckhoff, Katrin / Elf, Anna-Karin / Dahlberg, Jakob / Hermann, Michael

    The British journal of surgery

    2023  Volume 110, Issue 12, Page(s) 1824–1833

    Abstract: ... and 77 (32.1 per cent) in the control group had low levels of PTH after thyroidectomy (P = 0.141 ... relative risk (RR) 0.81, 95 per cent c.i. 0.61 to 1.07). Subanalysis of 174 patients undergoing central ... in the control group had low levels of PTH on postoperative day 1 (P = 0.021; RR 0.54, 0.31 to 0.93). More ...

    Abstract Background: Techniques for autofluorescence have been introduced to visualize the parathyroid glands during surgery and to reduce hypoparathyroidism after thyroidectomy.
    Methods: This parallel multicentre RCT investigated the use of Fluobeam® LX to visualize the parathyroid glands by autofluorescence during total thyroidectomy compared with no use. There was no restriction on the indication for surgery. Patients were randomized 1 : 1 and were blinded to the group allocation. The hypothesis was that autofluorescence enables identification and protection of the parathyroid glands during thyroidectomy. The primary endpoint was the rate of low parathyroid hormone (PTH) levels the day after surgery.
    Results: Some 535 patients were randomized, and 486 patients received an intervention according to the study protocol, 246 in the Fluobeam® LX group and 240 in the control group. Some 64 patients (26.0 per cent) in the Fluobeam® LX group and 77 (32.1 per cent) in the control group had low levels of PTH after thyroidectomy (P = 0.141; relative risk (RR) 0.81, 95 per cent c.i. 0.61 to 1.07). Subanalysis of 174 patients undergoing central lymph node clearance showed that 15 of 82 (18 per cent) in the Fluobeam® LX group and 31 of 92 (33 per cent) in the control group had low levels of PTH on postoperative day 1 (P = 0.021; RR 0.54, 0.31 to 0.93). More parathyroid glands were identified during operation in patients who had surgery with Fluobeam® LX, and fewer parathyroid glands in the surgical specimen on definitive histopathology. No specific harm related to the use of Fluobeam® LX was reported.
    Conclusion: The use of autofluorescence during thyroidectomy did not reduce the rate of low PTH levels on postoperative day 1 in the whole group of patients. It did, however, reduce the rate in a subgroup of patients. Registration number: NCT04509011 (http://www.clinicaltrials.gov).
    MeSH term(s) Humans ; Parathyroid Glands/surgery ; Thyroidectomy/adverse effects ; Thyroidectomy/methods ; Parathyroid Hormone ; Hypoparathyroidism/etiology ; Hypoparathyroidism/prevention & control ; Lymph Nodes ; Postoperative Complications/etiology ; Postoperative Complications/prevention & control ; Postoperative Complications/surgery ; Hypocalcemia/etiology
    Chemical Substances Parathyroid Hormone
    Language English
    Publishing date 2023-09-27
    Publishing country England
    Document type Randomized Controlled Trial ; Multicenter Study ; Journal Article
    ZDB-ID 2985-3
    ISSN 1365-2168 ; 0263-1202 ; 0007-1323 ; 1355-7688
    ISSN (online) 1365-2168
    ISSN 0263-1202 ; 0007-1323 ; 1355-7688
    DOI 10.1093/bjs/znad278
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Therapeutische Modulation der Darmmikrobiota beim Reizdarmsyndrom. Von Probiotika bis zur fäkalen Mikrobiota-Therapie

    Konturek, P. C. / Zopf, Y.

    MMW - Fortschritte der Medizin : Originalien

    2017  Volume -, Issue 4 = Suppl.7, Page(s) 1

    Language German
    Document type Article
    ZDB-ID 2126515-X
    ISSN 1438-3276
    Database Current Contents Medicine

    More links

    Kategorien

To top